Luseogliflozin reduces epicardial fat accumulation in patients with type 2 diabetes: a pilot study

BACKGROUND: Accumulation of epicardial fat (EF) is associated with increased cardio-metabolic risks and coronary events, independently of traditional cardiovascular risk factors. Therefore, the reduction of EF volume (EFV) may be associated with reduced cardio-metabolic risks and future cardiovascul...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cardiovasc Diabetol
Autors principals: Bouchi, Ryotaro, Terashima, Masahiro, Sasahara, Yuriko, Asakawa, Masahiro, Fukuda, Tatsuya, Takeuchi, Takato, Nakano, Yujiro, Murakami, Masanori, Minami, Isao, Izumiyama, Hajime, Hashimoto, Koshi, Yoshimoto, Takanobu, Ogawa, Yoshihiro
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2017
Matèries:
Original Investigation
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5335851/
https://ncbi.nlm.nih.gov/pubmed/28253918
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12933-017-0516-8
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars